Pfizer pays clean air fine
Pharma Compliance Alert, July 2, 2008
Pfizer became the first pharmaceutical company to pay a fine under the PharmaMACT, a 2000 law designed to control the emissions of hazardous air pollutants from pharmaceutical manufacturing operations.
Pfizer agreed to pay a $975,000 civil penalty to resolve allegations it violated the Clean Air Act at its former manufacturing plant in Groton, CT between October 2002 and December 2005, according to a Department of Justice (DOJ) release. Pfizer shut down the plant in January.
During its production of pharmaceutical-grade chemicals, Pfizer used substances such as methanol, hydrogen chloride, methylene chloride, MTBE, hexane, toluene, and many others, classified by the Environmental Protection Agency as hazardous air pollutants. The alleged violations resulted from a failure of Pfizer’s leak detection and repair (LDAR) program.
The specific violations included failure to:
- Properly conduct pressure tests to identify leaks
- Repair leaks before start-up
- Equip open-ended lines with a cap or other seal
- Document leak tests to establish full compliance with the LDAR requirements
Comments
0 comments on “Pfizer pays clean air fine ”
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched
